Market Tracker

10/18 5:16pm ET

NovaBay Pharmaceuticals Inc (NYSE American:NBY)

4.50
Delayed Data
As of Oct 18
 +0.15 / +3.45%
Today’s Change
2.25
Today|||52-Week Range
5.09
+36.36%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close4.35
Today’s open4.30
Day’s range4.30 - 4.60
Volume3,814
Average volume (3 months)16,610
Market cap$66.6M
Dividend yield--
Data as of 3:57pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+79.47%
Earnings growth (this year)+67.50%
Earnings growth (next 5 years)--
Revenue growth (last year)+171.56%
P/E ratioNM
Price/Sales2.61
Price/Book9.35

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...-0.00-4.08%
AGLEAeglea Bio Therapeut...-0.15-2.93%
RNNRexahn Pharmaceutica...-0.03-1.49%
PTNPalatin Technologies...+0.06+8.51%
Data as of 7:59pm ET, 10/18/2017

Financials

Next reporting dateNovember 10, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.9M
Annual profit (last year)-$13.2M
Net profit margin-110.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer
Jack J. McGovern
Corporate headquarters
Emeryville, California

Forecasts